Trahan Jeremy 4

What Happened

• Jeremy Trahan, General Counsel of Viemed Healthcare (VMD), converted/exercised company awards on January 21, 2026. The filing shows conversions of 14,648 and 3,662 derivative units (RSUs/phantom shares) and the vesting/settlement of related awards.
• To cover tax obligations and a cash settlement, 4,783 shares were withheld by the issuer (tax withholding) for $7.49/share (total $35,825) and 3,662 shares were delivered back to the issuer for $7.49/share (total $27,428). Combined proceeds (withholding + settlement) are about $63,253.
• These were not open-market purchases — they reflect the conversion/vesting of equity-based awards and internal share transfers to the company for taxes/settlement (commonly a cashless or net-share settlement).

Key Details

• Transaction date: January 21, 2026; Form 4 filed January 23, 2026.
• Reported entries: conversions/exercises of 14,648 and 3,662 derivative units; 4,783 shares withheld for taxes (code F) at $7.49/share = $35,825; 3,662 shares disposed to issuer (code D) at $7.49/share = $27,428.
• Per-share value basis: market close price on January 21, 2026 (footnote F3).
• Shares owned after the transactions: not specified in the provided excerpt of the filing.
• Notable footnotes: F1–F6 indicate these were RSUs and phantom share units (phantom shares are cash-settled equivalents of common stock), tax withholding to satisfy vesting-related tax obligations, and the awards were originally granted Jan 21, 2025 with vesting in three annual installments.
• Filing timeliness: appears timely (transaction 1/21/2026; filing 1/23/2026); no late filing indicated.

Context

• This activity represents routine settlement of equity compensation rather than an outright open-market sale or purchase. The conversion/vesting of RSUs and cash-settled phantom shares followed by withholding or share surrender to the company is a common cashless/settlement practice to cover taxes and cash obligations.
• For retail investors: these transactions confirm the executive received and settled equity awards but do not necessarily signal the insider's buy/sell market sentiment.